Gallbladder Cancer
What's New
Last Posted: Dec 13, 2022
- A Gallbladder Cancer Survival Prediction Model Based on Multimodal Fusion Analysis.
Yin Ziming et al. Digestive diseases and sciences 2022 - Comprehensive clinicopathological and genomic profiling of gallbladder cancer reveals actionable targets in half of patients.
de Bitter Tessa J J et al. NPJ precision oncology 2022 6(1) 83 - Clinical Implications of BRCA Mutations in Advanced Biliary Tract Cancer.
Kim Hyera et al. Oncology 2022 - Using machine learning to preoperatively stratify prognosis among patients with gallbladder cancer: a multi-institutional analysis.
Cotter Garrett et al. HPB : the official journal of the International Hepato Pancreato Biliary Association 2022 - Germline cancer susceptibility gene testing in unselected patients with hepatobiliary cancers: A multi-center prospective study.
Uson Junior Pedro Ls et al. Cancer prevention research (Philadelphia, Pa.) 2021 - Comparison of Prediction Models for Acute Kidney Injury Among Patients with Hepatobiliary Malignancies Based on XGBoost and LASSO-Logistic Algorithms.
Zhang Yunlu et al. International journal of general medicine 2021 141325-1335 - Genomic profiling reveals high frequency of DNA repair genetic aberrations in gallbladder cancer.
Abdel-Wahab Reham et al. Scientific reports 2020 Dec 10(1) 22087 - Biliary tract cancer prognostic and predictive genomics.
Mondaca Sebastian et al. Chinese clinical oncology 2019 Aug 8(4) 42 - Therapeutic relevance of targeted sequencing in management of patients with advanced biliary tract cancer: DNA damage repair gene mutations as a predictive biomarker.
Chae Heejung et al. European journal of cancer (Oxford, England : 1990) 2019 Aug 12031-39 - Regional differences in gallbladder cancer pathogenesis: Insights from a multi-institutional comparison of tumor mutations.
Narayan Raja R et al. Cancer 2018 Nov
More
About Rare Diseases PHGKB
Rare Disease PHGKB is an online, continuously updated, searchable database of published scientific literature, CDC and NIH resources, and other information that address the public health impact and translation of genomic and other precision health discoveries into improved health outcomes related to rare diseases...more
Content Summary
Selected Rare Diseases
- Alpha-1 Antitrypsin Deficiency
- Amyotrophic Lateral Sclerosis
- Brugada Syndrome
- Cerebral Palsy
- Cystic Fibrosis
- Duchenne Muscular Dystrophy
- Eclampsia
- Erythema Multiforme
- Familial Mediterranean Fever
- Fragile X Syndrome
- Gaucher Disease
- Glomerulonephritis
- Graves Disease
- Hemophilia
- Huntington Disease
- Microcephaly
- Myasthenia Gravis
- Phenylketonuria
- Retinitis Pigmentosa
- Severe Combined Immunodeficiency
Disclaimer: Articles listed in the Public Health Knowledge Base are selected by Public Health Genomics Branch to provide current awareness of the literature and news. Inclusion in the update does not necessarily represent the views of the Centers for Disease Control and Prevention nor does it imply endorsement of the article's methods or findings. CDC and DHHS assume no responsibility for the factual accuracy of the items presented. The selection, omission, or content of items does not imply any endorsement or other position taken by CDC or DHHS. Opinion, findings and conclusions expressed by the original authors of items included in the update, or persons quoted therein, are strictly their own and are in no way meant to represent the opinion or views of CDC or DHHS. References to publications, news sources, and non-CDC Websites are provided solely for informational purposes and do not imply endorsement by CDC or DHHS.
- Page last reviewed:Feb 1, 2024
- Page last updated:May 01, 2024
- Content source: